Back

Phenotypes of pharmacological treatment in patients with atrial fibrillation: a latent class analysis from the prospective GLORIA-AF Registry Phase III

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Registries, observational, and other studies on atrial fibrillation Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Bernadette Corica

University of Modena and Reggio Emilia, Modena (Italy)

5 More presentations in this session

Presentation thumbnail
Refining the CHA2DS2VASc risk stratification scheme: Shall we drop the Sex Category?
Professor R. Providencia (London, GB)
Slides Video
Presentation thumbnail
Biomarkers for improved risk prediction and biological insights in patients with atrial fibrillation
Associate Professor D. Conen (Hamilton, CA)
Slides Video
Presentation thumbnail
Incidence of atrial fibrillation in cryptogenic stroke with patent foramen ovale closure:the PFO-AF study
Doctor M. Badoz (Besancon, FR)
Slides Video
Presentation thumbnail
A comparison of vascular brain lesions on magnetic resonance imaging in patients with atrial fibrillation and patients with atherosclerosis
Doctor T. Stegmann (Leipzig, DE)
Slides Video
Presentation thumbnail
Longterm 13 Year Outcome of AF Ablation in Elderly Patients - German Ablation Registry
Professor J. Brachmann (Coburg, DE)
Slides Video

Access the full session

Session thumbnail
Registries, observational, and other studies on atrial fibrillation
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources